(Q45407116)

English

Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).

scientific article published in March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

10

1 reference

Europe PubMed Central

14 December 2017

author name string

E Rosenthal

1

1 reference

Europe PubMed Central

14 December 2017

G Pialoux

2

1 reference

Europe PubMed Central

14 December 2017

N Bernard

3

1 reference

Europe PubMed Central

14 December 2017

C Pradier

4

1 reference

Europe PubMed Central

14 December 2017

D Rey

5

1 reference

Europe PubMed Central

14 December 2017

M Bentata

6

1 reference

Europe PubMed Central

14 December 2017

C Michelet

7

1 reference

Europe PubMed Central

14 December 2017

S Pol

8

1 reference

Europe PubMed Central

14 December 2017

C Perronne

9

1 reference

Europe PubMed Central

14 December 2017

GERMIVIC Joint Study Group

11

1 reference

Europe PubMed Central

14 December 2017

publication date

1 March 2007

1 reference

Europe PubMed Central

14 December 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

14 December 2017

14

1 reference

Europe PubMed Central

14 December 2017

3

1 reference

Europe PubMed Central

14 December 2017

183-188

1 reference

Europe PubMed Central

14 December 2017

Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Management of chronic hepatitis C in French departments of internal medicine and infectious diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00791.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2006.00791.X

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45407116&oldid=2135956047"